Treatment of Patients With Diabetic Kidney Disease

• Status: Not yet recruiting
• Trial end date: 2025-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Due to irrespective of the limitations associated with estimated glomerular filtration rate (eGFR), it is crucial to develop new treatments that can effectively address these concerns. So, this study aimed to compare the effectiveness of SGlT2i versus ACEi in the progression of diabetic kidney disease including progression of albuminuria. Doubling of serum creatinine and need for renal replacement therapy

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Dapagliflozin; Empagliflozin; Enalapril; Lisinopril

Criteria

Inclusion Criteria:

• Patients that suffer from Diabetic kidney disease (DKD)

Exclusion Criteria:

• Genital mycotic infections

• Urosepsis and Pyelonephritis

• Lower limb amputation

• diabetic Ketoacidosis

• Euglycemic DKA

• Acute Kidney Injury

• Hypoglycemia

• Fournier Gangrene

• Hypersensitivity Reactions

• Bone fracture

• Bladder cancer

• Hyperkalemia

• Dyslipidemia